Tricida, Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tricida, Inc. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 23.91 | 4,000 | 95,640 | 41,323 | 45.3 K to 41.3 K (-8.83 %) |
| Mar 11 2020 | TCDA | Tricida, Inc. | McKague Robert | EVP, General Counse ... | Option Exercise | A | 31.14 | 210,000 | 6,539,400 | 210,000 | |
| Mar 11 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 29.46 | 5,000 | 147,300 | 55,000 | 50 K to 55 K (+10.00 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 7.49 | 523 | 3,917 | 24,079 | |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 2.39 | 523 | 1,250 | 17,798 | |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 2,994 | 5,030 | 8,812 | |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 210 | 353 | 840 | |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 2.39 | 523 | 1,250 | 778 | 255 to 778 (+205.10 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.78 | 2,994 | 95,149 | 255 | 3.2 K to 255 (-92.15 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 2,994 | 5,030 | 3,249 | 255 to 3.2 K (+1,174.12 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 210 | 6,716 | 255 | 465 to 255 (-45.16 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Option Exercise | M | 0.96 | 10,000 | 9,600 | 104,143 | |
| Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Sell | S | 32.23 | 200 | 6,446 | 19,153 | 19.4 K to 19.2 K (-1.03 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Buy | M | 0.96 | 200 | 192 | 19,353 | 19.2 K to 19.4 K (+1.04 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Sell | S | 31.65 | 9,800 | 310,170 | 19,153 | 29 K to 19.2 K (-33.85 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Buy | M | 0.96 | 9,800 | 9,408 | 28,953 | 19.2 K to 29 K (+51.17 %) |
| Mar 04 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 31.53 | 4,000 | 126,120 | 563,321 | 567.3 K to 563.3 K (-0.71 %) |